Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Nicole DeFeudis
EDITOR, ENDPOINTS NEWS
The Evolving Landscape of Immunotherapy in Solid Cancers
Stephane Degove, BSc
CEO, ATAMYO THERAPEUTICS
ATAMYO THERAPEUTICS
Paris, France
Julio Delgado
DEPARTMENT OF HAEMATOLOGY, HOSPITAL CLINIC, IDIBAPS, UNIVERSITY OF BARCELONA, SPAIN
Academic Development of Cell and Gene Therapies: Three Different Perspectives, Including EMA and Academia
Placeholder Photo
Geraldine Deliencourt-Godefroy, PhD
CHIEF SCIENTIFIC OFFICER, SIRONA BIOCHEM CORPORATION
Sirona Biochem Corp
Val De Reuil, France
Pierre Delsaux
DIRECTOR-GENERAL, HEALTH EMERGENCY AND PREPAREDNESS RESPONSE AUTHORITY, EUROPEAN COMMISSION
Enhancing Public Health Preparedness through Policy and Partnership
Vaccine Manufacturing in Africa: Challenges and Opportunities
The Road to Global Alignment: A Discussion on International Regulatory Harmonization
Jennifer Dent
PRESIDENT, BIO VENTURES FOR GLOBAL HEALTH
The Cancer Moonshot in Africa: Improving Cancer Patient Outcomes through Public-Private Partnerships
Atul Deshpande, PhD
CHIEF STRATEGY OFFICER, PEPTILOGICS
Peptilogics Inc.
Pittsburg, Pennsylvania, United States
Scott DeWire, PhD
US HEAD, BUSINESS DEVELOPMENT & LICENSING, BOEHRINGER INGELHEIM
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut, United States
John DeYoung
VP, WORLDWIDE BUSINESS DEVELOPMENT – ONCOLOGY, PFIZER INC.
How to Strike a Deal in Oncology: Innovative Partnering Approaches Across Biotech and Pharma
New York, New York, United States
Rachel Diamant
CBO, EMENDOBIO
EmendoBio
NY, New York, United States